Defining invasive fungal infections in neutropenic or stem cell transplant patients

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue SUPPL. 1, 2005, Pages

  Kibbler, Chris ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

CT scanning; Galactomannan; Invasive aspergillosis

Indexed keywords

GALACTOMANNAN; RADIOISOTOPE;

CANCER THERAPY; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EUROPE; FUTUROLOGY; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; MEDICAL LITERATURE; MICROBIOLOGY; MYCOSIS; NEUTROPENIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STANDARDIZATION; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; TREATMENT PLANNING;

HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; NEUTROPENIA; STEM CELL TRANSPLANTATION;

EID: 24144434735     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki219     Document Type: Review

References (34)

1. Sington JD, Cottrell BJ. Analysis of the sensitivity of death certificates in 440 hospital deaths: A comparison with necropsy findings. J Clin Pathol 2002; 55: 499-502.
2. Denning DW. Empirical therapy of fungal infections in neutropenic patients. Prescr J 1998; 38: 175-82.
3. Kibbler CC, Ainscough S, Barnes RA et al. Management and outcome of blood stream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54: 18-24.
4. Riley LC, Hann IM, Wheatley K et al. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party. Br J Haematol 1999; 106: 436-44.
5. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign and the role of CT in early diagnosis. Radiology 1985; 157: 611-4.
6. Kibbler CC, Milkins SR, Bhamra A et al. Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients. Thorax 1988; 43: 108-12.
7. Graham NJ, Muller NL, Miller RR et al. Intrathoracic complications following allogeneic bone marrow transplantation: CT findings. Radiology 1991; 181: 153-6.
8. Caillot D, Couaillier JF, Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-9.
9. Yeghen T, McWhinney PHM, Kibbler CC et al. Management of invasive pulmonary aspergillosis in haematology patients: A review of 87 consecutive cases at a single institution. Clin Infect Dis 2000; 31: 859-68.
10. Pagano L, Mele L, Fianchi L et al. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes. Haematologica 2002; 87: 535-41.
11. Blum U, Windfuhr M, Buitrago-Tellez C et al. Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest 1994; 106: 1156-61.
12. DeLone DR, Goldstein RA, Petermann G et al. Disseminated aspergillosis involving the brain: Distribution and imaging characteristics. Am J Neuroradiol 1999; 20: 1597-604.
13. Ozsahin H, von Planta M, Muller I et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 1998; 92: 2719-24.
14. Wilkinson MD, Fulham MJ, McCaughan BC et al. Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography. Clin Nucl Med 2003; 28: 234-5.
15. Becker MJ, Dams ET, de Marie S et al. Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats. Nucl Med Biol 2002; 29: 177-84.
16. Dams ET, Becker MJ, Oyen WJ et al. Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats. J Nuct Med 1999; 40: 2066-72.
17. Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003; 3: 230-40.
18. Fenelon LE, Hamilton AJ, Figueroa A et al. Production of specific monoclonal antibodies to Aspergillus species and their use in immunohistochemical identification of aspergillosis. J Clin Microbiol 1999; 37: 1221-3.
19. Paterson PJ, Seaton S, McLaughlin J et al. Development of molecular methods for the identification of aspergillus and emerging moulds in paraffin wax embedded tissue sections. Mol Pathol 2003; 56: 368-70.
20. Horvath JA, Dummer S. The use of respiratory-tract culture in the diagnosis of invasive aspergillosis. Am J Med 1996; 100: 171-8.
21. Pagano L, Pagliari G, Basso A et al. The role of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients with haematological malignancies. Ann Med 1997; 29: 535-40.
22. Levy H, Horak DA, Tegtmeier BR et al. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992; 86: 243-8.
23. Walsh TJ, Melcher GP, Lee JW et al. Infections due to Trichosporon species: New concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol 1993; 5: 79-113.
24. Chanock SJ, Toltzis P, Wilson C. Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen. Lancet 1993; 342: 1119-20.
25. Hopfer RL, Perry EV, Fainstein V. Diagnostic value of cryptococcal antigen in the cerebrospinal fluid of patients with a malignant disease. J Infect Dis 1982; 145: 915.
26. Engler HD, Shea YR. Effect of potential interference factors on performance of enzyme immunoassay and latex agglutination assay for cryptococcal antigen. J Clin Microbiol 1994; 32: 2307-8.
27. Maertens J, Verhaegen J, Demuynck H et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol 1999; 37: 3223-8.
28. Ansorg R, van den Boom R, Rath PM, Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997; 40: 353-7.
29. Einsele H, Hebart H, Roller G et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997; 35: 1353-60.
30. Ascioglu S, de Pauw BE, Donnelly JP et al. Reliability of clinical research on invasive fungal infections: A systematic review of the literature. Med Mycol 2001; 39: 35-40.
31. Ascioglu S, Rex JH, de Pauw B et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.
32. Walsh TJ, Teppler H, Donowitz GR et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351 1391-402.
33. Subira M, Martino R, Rovira M et al. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003; 82: 80-2.
34. Denning DW, Evans EGV, Kibbler CC et al. Eur J Clin Microbiol Infect Dis 1997; 16: 424-36.